The Oncology Institute, Inc. (TOI) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped TOI stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: The Oncology Institute, Inc. (TOI) demonstrates strong potential for significant market outperformance due to strategic partnerships, high revenue growth expectations, and expanding telehealth and R&D capabilities. While challenges including operational cost issues and regulatory delays persist, the positive forecasted drivers far outweigh potential setbacks. Given the analyst consensus and a transformative market presence in oncology, TOI presents a compelling investment opportunity for both medium and long-term horizons. The saved 1-year distribution is P10 $2.3, P50 $6, and P90 $7.5.
Last analyzed · Model: gpt-4o
The Oncology Institute, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $2.3 | Pessimistic plausible scenario |
| P50 | $6 | Median scenario |
| P90 | $7.5 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
The strong analyst consensus with a mean price target nearly double its current price suggests high upside potential. Positive headlines indicate operational growth and strategic expansions, supporting a bullish stance. Risks include the regulatory challenges and competition.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this TOI analysis generated?
March 18, 2026.
Is this a guaranteed TOI prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full TOI stock analysis · TOI sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.